Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Papenburg

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
The Lancet. Infectious Diseases|March 20, 2023
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing dataDeidre Wilkins, Annefleur C Langedijk, Robert Jan Lebbink, et al.
European Journal of Pediatrics|February 26, 2022
Infants hospitalized for acute COVID-19: disease severity in a multicenter cohort studyJoanna Merckx, Shaun K Morris, Ari Bitnun, et al.
BMJ Paediatrics Open|September 2, 2022
Risk factors for severe PCR-positive SARS-CoV-2 infection in hospitalised childrenTilmann Schober, Chelsea Caya, Michelle Barton, et al.
Pediatric Research|June 5, 2023
Paediatric inflammatory multisystem syndrome in Canada: population-based surveillance and role of SARS-CoV-2 linkageTala El Tal, Marie-Paule Morin, Shaun K Morris, et al.
The Lancet. Global Health|September 16, 2017
Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case seriesNienke M Scheltema, Angela Gentile, Florencia Lucion, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
Frontiers in Pediatrics|November 28, 2022
Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countriesXavier Carbonell-Estrany, Eric A F Simões, Louis J Bont, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
The Lancet. Infectious Diseases|March 20, 2023
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing dataDeidre Wilkins, Annefleur C Langedijk, Robert Jan Lebbink, et al.
European Journal of Pediatrics|February 26, 2022
Infants hospitalized for acute COVID-19: disease severity in a multicenter cohort studyJoanna Merckx, Shaun K Morris, Ari Bitnun, et al.
BMJ Paediatrics Open|September 2, 2022
Risk factors for severe PCR-positive SARS-CoV-2 infection in hospitalised childrenTilmann Schober, Chelsea Caya, Michelle Barton, et al.
Pediatric Research|June 5, 2023
Paediatric inflammatory multisystem syndrome in Canada: population-based surveillance and role of SARS-CoV-2 linkageTala El Tal, Marie-Paule Morin, Shaun K Morris, et al.
The Lancet. Global Health|September 16, 2017
Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case seriesNienke M Scheltema, Angela Gentile, Florencia Lucion, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
Frontiers in Pediatrics|November 28, 2022
Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countriesXavier Carbonell-Estrany, Eric A F Simões, Louis J Bont, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 17